Espumisan L40 oral emulsion 40mg / ml, 30ml

symptoms of flatulence: bloating, a feeling of fullness and fullness in the epigastric region, increased gas formation (including in the postoperative period, as well as in newborns and infants;

intestinal colic;

preparation for diagnostic examinations of the abdominal cavity and small pelvis organs (ultrasound, radiography, etc.), incl. as an additive to suspensions of contrast agents for obtaining images by the method of double contrast;

poisoning with tensides (including surfactants that are part of detergents) as an antifoam agent.

Inside. Shake the bottle with the emulsion before use. The drug can be dispensed in drops or in milliliters using a measuring cap. For drip dispensing, the bottle must be held vertically with the opening down.

The drug is taken during or after meals, and, if necessary, before bedtime.

The frequency of admission and the duration of use depend on the severity of the symptoms. If necessary, EspumisanЃ L can be taken for a long time

For complaints associated with excessive flatulence and intestinal colic

Children from birth to 1 year: 1 ml (25 drops) of EspumisanЃ L each time the baby feeds (added to a bottle with baby food or given with a small spoon during or after feeding).

Children from 1 to 6 years old: 1 ml (25 drops) of EspumisanЃ L 3-5 times a day.

Children from 6 years old to 14 years old: 1-2 ml (25-50 drops) of EspumisanЃ L 3-5 times a day.

Children from 14 years old and adults: 2 ml (50 drops) of EspumisanЃ L 3-5 times a day.

In preparation for X-ray and ultrasound examination

Apply 2 ml (50 drops) of the EspumisanЃ L preparation 3 times a day the day before the study and 2 ml (50 drops) of the EspumisanЃ L preparation in the morning of the study day.

To obtain a double contrast image

Add 4-8 ml of EspumisanЃ L per 1 liter of contrast suspension.

In preparation for esophagogastroduodenoscopy

Inside 4-8 ml of the drug EspumisanЃ L before the study. During endoscopy, if necessary, a few milliliters of emulsion can be injected through the endoscope channel to eliminate gas bubbles that interfere with the examination.

In case of acute poisoning with detergents containing surfactants.

Children - 2.5-10 ml of EspumisanЃ L, adults - 10-20 ml of EspumisanЃ L, depending on the severity of the poisoning.

Active ingredient: simethicone * - 40.00 mg

Excipients: macrogol stearate - 6.560 mg, glyceryl monostearate 40-55 - 4.020 mg, carbomer - 6.350 ml, banana flavor - 4.233 mg, potassium acesulfame - 0.318 mg, liquid sorbitol (non-crystallizing) - 211.655 mg, sodium chloride - 0.708 mg sodium citrate - 4.445 mg, sodium hydroxide - 0.708 mg, sorbic acid - 1.060 mg, purified water - 778.245 mg.

* Simethicone consists of dimethicone (polydimethylsiloxane (PDMS)) and silicon dioxide in a ratio of 96: 4

Hypersensitivity to the components of the drug, intestinal obstruction, hereditary fructose intolerance.

Trade name of the drug: EspumisanЃL

International non-proprietary name: Simethicone

Dosage form: oral emulsion

Composition:

1 ml (25 drops) of the drug contains:

Active ingredient: simethicone * - 40.00 mg

Excipients: macrogol stearate - 6.560 mg, glyceryl monostearate 40-55 - 4.020 mg, carbomer - 6.350 ml, banana flavor - 4.233 mg, potassium acesulfame - 0.318 mg, liquid sorbitol (non-crystallizing) - 211.655 mg, sodium chloride - 0.708 mg sodium citrate - 4.445 mg, sodium hydroxide - 0.708 mg, sorbic acid - 1.060 mg, purified water - 778.245 mg.

* Simethicone consists of dimethicone (polydimethylsiloxane (PDMS)) and silicon dioxide in a ratio of 96: 4

Description

Slightly viscous milky white emulsion with a banana scent.

Pharmacotherapeutic group: Carminative

ATX code: A03AX13

Pharmachologic effect:

Pharmacodynamics

The active substance is simethicone, which reduces the amount of gases in the gastrointestinal tract (GIT): it has surface-active properties and the ability to reduce surface tension at the liquid / gas interface, which makes it difficult to form gas bubbles, and also contributes to their fusion and destruction of foam in intestines, as a result of which the released gas is absorbed and excreted naturally under the influence of intestinal motility. The use of simenthicone in preparation for diagnostic studies prevents the occurrence of image defects caused by gas bubbles.

Pharmacokinentika

Simethicone is chemically inert, after oral administration it is not absorbed from the gastrointestinal tract and acts only in its lumen. Does not interact with microorganisms and enzymes and does not affect digestion processes. It is excreted by the intestines unchanged.

Indications for use

symptoms of flatulence: bloating, a feeling of fullness and fullness in the epigastric region, increased gas formation (including in the postoperative period, as well as in newborns and infants;

intestinal colic;

preparation for diagnostic examinations of the abdominal cavity and small pelvis organs (ultrasound, radiography, etc.), incl. as an additive to suspensions of contrast agents for obtaining images by the method of double contrast;

poisoning with tensides (including surfactants that are part of detergents) as an antifoam agent.

Method of administration and dosage